Geron strategic restructuring plan focuses on Rytelo growth
Source: SeekingAlpha
2025-12-16 17:49:59 ET
More on Geron
- Geron Corporation: Can Restructuring Bring The Stock Back To Life? I'm On The Sidelines
- Geron: Rytelo Launch Stalls Out, EU Partnership And IMpactMF Results Could Help
- Geron Corporation (GERN) Q3 2025 Earnings Call Transcript
- Geron to lay off a third of workforce under restructuring program
- Geron signals 2026 growth focus as RYTELO new patient starts rise to 36% in Q3
Read the full article on Seeking Alpha
For further details see:
Geron strategic restructuring plan focuses on Rytelo growth
Geron Corporation
NASDAQ: GERN
GERN Trading
-4.1% G/L:
$1.575 Last:
9,309,475 Volume:
$1.63 Open:
GERN Latest News
February 25, 2026 07:00:00 am
Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
GERN Stock Data
$1,030,943,769
590,989,314
0.47%
88
N/A
Biotechnology & Life Sciences
Healthcare
US
FOSTER CITY
